Pfizer is suing over some unsolicited competition in its nearly $5 billion bid to buy the drugmaker Metsera. New York-based Pfizer said Friday after markets closed that it was suing Metsera and a ...

With a new generation of weight-loss drugs entering Indian markets, spelling hope for many, The Indian Express tracks the conversations and communities, confusion and clarity that surround those on th ...

An expert said weight loss drugs might help people see faster results, which can give them encouragement to continue. But he ...

New Scripps Research trial will explore the effects of Lilly’s GLP-1 drug on reducing the symptoms of the debilitating ...

Wegovy Zepbound cost-effectiveness report finds both drugs remain valuable at higher prices despite affordability concerns, per ICER analysis.

Founded in 2022 by Population Health Partners and ARCH Venture Partners, the biotech venture giant led by Bob Nelsen, Metsera ...

Denmark's Novo Nordisk launched a rival bid for U.S. obesity biotech firm Metsera on Thursday, hijacking an offer from Pfizer ...

The market for obesity and diabetes treatments remains scorching hot, funneling billions in sales to Eli Lilly.

The Gallup National Health and Well-Being Index shows that GLP-1 weight loss drugs are having an effect: The U.S. obesity ...

Would you give Wegovy to your child if it stopped them being bullied? - COMMENT : It might sound shocking to read about such ...

Popular weight-loss drugs Ozempic and Wegovy are now available at more than 500 Costco pharmacies across the United States. Novo Nordisk, the company that produces both brands of the semaglutide ...